Searchable abstracts of presentations at key conferences in endocrinology

ea0026p701 | Diabetes complications | ECE2011

Receptor activator of nuclear factor kappa β ligand and osteoprotegerin levels in the patients with diabetic nephropathy

Kuzuguden Cigdem , Guldiken Sibel , Ustundag Sedat , Ozgen Zeren , Demir Muzaffer

Aim: The aim of this study was to investigate the relationship between the clinical and laboratory findings of metabolic bone disease regarding the levels of osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa B ligand (RANKL) in the patients with diabetic nephropathy.Material and method: This study includes 61 type 2 diabetic patients and age-, sex-matched 20 healthy subjects. Diabetic patients were divided into three groups accordi...